Article Details

Long-Term Follow-Up Shows Survival Benefit Maintained for Daratumumab Added to SOC in ...

Retrieved on: 2021-06-12 19:41:15

Tags for this article:

Click the tags to see associated articles and topics

Long-Term Follow-Up Shows Survival Benefit Maintained for Daratumumab Added to SOC in .... View article details on hiswai:

Excerpt

“These results strongly support upfront daratumumab with lenalidomide and dexamethasone as a new standard of care for patients with transplant- ...

Article found on: www.targetedonc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up